SynAct Pharma AB (publ) (“SynAct”) today announced that the Nomination Committee in preparation for the Annual General Meeting (AGM) 2023 on
Pursuant to the instruction and charter for the Nomination Committee adopted at the AGM held on
Based on the above, the
Niels Ankerstjerne Sloth , appointed byBioinvest ApS Jens Bager , appointed byGL Capital AB Steen Christensen , appointed byNext Stage Ventures ApS Torbjørn Bjerke , Chairman of the Board of Directors
The Nomination Committee's tasks for the AGM 2023 are to propose a Chairman for the AGM, members of the Board of Directors and Chairman of the Board of Directors as well as auditor. The Nomination Committee will also propose remuneration to members and the Chairman of the Board of Directors as well as proposal for remuneration of the auditor. Finally, the Nomination Committee will propose principles for appointing the Nomination Committee (if the Nomination Committee considers that the current principles and instructions should be updated).
Shareholders are welcome to submit their proposals and views to the Nomination
The Nomination Committee's proposals will be announced in the notice for the AGM 2023 and on SynAct’s web site.
The information was submitted, through the agency of the contact person below, for publication at
© Modular Finance, source